The change would not legalize the drug on the federal level, but would ease barriers on research using cannabis.

President Trump is expected to sign an order that would reschedule marijuana to a lower drug classification, according to two sources, in one of the most significant changes to drug policy in decades.

President Trump signed an executive order on Thursday to reschedule marijuana to a lower drug classification, one of the most significant changes to drug policy in decades.

The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.

The Kentucky Equine Drug Research Council has formed a committee to examine the 170 differences between its drug and medication classification schedule, and the recommendations of the Association of ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

3 NSW Injury Risk Management Research Centre, University of New South Wales, Sydney 4 NSW Injury Risk Management Research Centre, University of New South Wales Correspondence to: Dr Rae Sports ...

Primary healthcare services rely on access to health products, including medicines, vaccines and medical devices. These products must be of assured safety, efficacy, performance and quality, as well ...